[(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate

C28H35N11O6 — CID 91287060

IUPAC[(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate
SMILESCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H](CO)Cc5ccccc5)nc(NCCN5CCCC5)nc43)[C@H](OC=O)[C@@H]2OC=O)n1
InChIInChI=1S/C28H35N11O6/c1-37-35-25(34-36-37)22-21(43-16-41)23(44-17-42)27(45-22)39-15-30-20-24(31-19(14-40)13-18-7-3-2-4-8-18)32-28(33-26(20)39)29-9-12-38-10-5-6-11-38/h2-4,7-8,15-17,19,21-23,27,40H,5-6,9-14H2,1H3,(H2,29,31,32,33)/t19-,21+,22-,23+,27+/m0/s1
InChIKeyLUPXHBXNUYEBJJ-DAPLBOTBSA-N
MW621.66 g/mol
LogP0.23
Rot. Bonds15

About [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate

[(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate (PubChem CID 91287060) has the molecular formula C28H35N11O6 and a molecular weight of 621.66 g/mol. Its IUPAC name is [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate.

Molecular Properties

Compound Name[(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate
PubChem CID91287060
Molecular FormulaC28H35N11O6
Molecular Weight621.66 g/mol
Exact Mass621.28
IUPAC Name[(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate
SMILESCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H](CO)Cc5ccccc5)nc(NCCN5CCCC5)nc43)[C@H](OC=O)[C@@H]2OC=O)n1
InChIInChI=1S/C28H35N11O6/c1-37-35-25(34-36-37)22-21(43-16-41)23(44-17-42)27(45-22)39-15-30-20-24(31-19(14-40)13-18-7-3-2-4-8-18)32-28(33-26(20)39)29-9-12-38-10-5-6-11-38/h2-4,7-8,15-17,19,21-23,27,40H,5-6,9-14H2,1H3,(H2,29,31,32,33)/t19-,21+,22-,23+,27+/m0/s1
InChIKeyLUPXHBXNUYEBJJ-DAPLBOTBSA-N
XLogP0.23
TPSA196.56 Ų
H-Bond Donors3
H-Bond Acceptors17
Rotatable Bonds15
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500621.66
LogP ≤ 50.23
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
The IUPAC name of [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate (CID 91287060) is [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate.
What is the SMILES notation for [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
The canonical SMILES for [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate is Cn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H](CO)Cc5ccccc5)nc(NCCN5CCCC5)nc43)[C@H](OC=O)[C@@H]2OC=O)n1.
What is the InChIKey of [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
The InChIKey is LUPXHBXNUYEBJJ-DAPLBOTBSA-N. The full InChI is InChI=1S/C28H35N11O6/c1-37-35-25(34-36-37)22-21(43-16-41)23(44-17-42)27(45-22)39-15-30-20-24(31-19(14-40)13-18-7-3-2-4-8-18)32-28(33-26(20)39)29-9-12-38-10-5-6-11-38/h2-4,7-8,15-17,19,21-23,27,40H,5-6,9-14H2,1H3,(H2,29,31,32,33)/t19-,21+,22-,23+,27+/m0/s1.
What are the key properties of [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
[(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate has a molecular weight of 621.66 g/mol, XLogP of 0.23, 15 rotatable bonds, 3 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5R)-4-formyloxy-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(2-pyrrolidin-1-ylethylamino)purin-9-yl]-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate is sourced from PubChem (CID 91287060), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).